Navigation Links
Michael Cusumano, MIT's Sloan Distinguished Professor of Management, Joins Quantum Leap Innovations Board of Directors
Date:11/29/2011

NEWARK, Del., Nov. 29, 2011 /PRNewswire-iReach/ --  Quantum Leap Innovations announced today the appointment of Michael A. Cusumano to their Board of Directors.  Michael Cusumano is the Sloan Management Review Distinguished Professor of Management at the Massachusetts Institute of Technology's Sloan School of Management, with a joint appointment in the MIT Engineering Systems Division. His seminal 2010 book, STAYING POWER, covers six enduring principles for managing strategy and innovation in an uncertain world.

(Photo:  http://photos.prnewswire.com/prnh/20111129/CG13879)

"We are honored to have someone of Dr. Cusamano's stature agree to join our board," said Quantum Leap founder and CEO Joseph Budner Elad. "His support validates our vision of Pattern Based Analytics and the importance of our technology in today's uncertain world."

"It is with great pleasure and excitement that I join the Quantum Leap board," says Dr. Cusumano. "I have known the principals in the company for many years and have closely followed the evolution of their work in data analysis.  The pattern-based analytics approach took years to develop. It significantly improves our ability to visualize and make sense of complex data sets and then apply these insights to a wide variety of business and other applications."

About Michael Cusumano:

Michael Cusumano specializes in strategy, product development, and entrepreneurship in the computer software industry, as well as automobiles and consumer electronics. He teaches courses on The Software Business and Digital Platforms as well as Strategic Management and Managing Technological Innovation and Entrepreneurship.

Professor Cusumano earned his B.A. degree from Princeton and his Ph.D. from Harvard.  He completed a pos
'/>"/>

SOURCE Quantum Leap Innovations
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
2. NeuroCog Trials Appoints Industry Executive Michael Hufford, Ph.D. to Chief Operating Officer
3. Oramed Pharmaceuticals Appoints Dr. Michael Berelowitz as Chairman of Scientific Advisory Board
4. Netsmart Technologies Names Michael Valentine as Chief Executive Officer
5. BioNeutral Appoints Michael D. Francis, J.D. as Director to the Board
6. Michael J. Fox Foundation Awards Grant to Zymes LLC
7. Dr. Michael Hanley Joins Celtaxsys as CEO
8. NeuroDerm Awarded $1M by The Michael J. Fox Foundation for the Clinical Development of a New Dermal Patch for Parkinsons Disease
9. Vaccinogen Names Veteran Biotech Executive Michael Kranda President & CEO
10. Michael J. Fox Foundation Launches Parkinsons Progression Markers Initiative (PPMI)
11. Epitomics, Inc. Announces Worldwide Availability of LRRK2 Antibodies Developed in Partnership With The Michael J. Fox Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... Athena Signature Series: Turning Cancer ‘Off’ – ... a professor in the Regulatory Biology Laboratory at the Salk ... points to an “off switch” for drug resistance in cancer. ... local research is making a global impact in the fight ... join host Cheryl K. Goodman, CEO of Social Global Mobile ...
(Date:11/18/2014)... Brothers Josh and Bryce Benbasat (ages ... PAWSitively Curing Cancer, Inc . in recognition of National ... organization is dedicated to raising funds for pet cancer ... University of Florida College of Veterinary Medicine . ... as the recipient of this vital funding. It will ...
(Date:11/18/2014)... 18, 2014 PDL BioPharma, Inc. (PDL) (NASDAQ: ... with the acquisition of Durata Therapeutics, Inc. by Actavis, ... the termination of PDL,s credit agreement with Durata, which ... $40 million, accrued interest, and prepayment and change of ... structured financing transaction with Durata in which PDL agreed ...
(Date:11/18/2014)... , Nov. 18, 2014  Novira Therapeutics, Inc., a ... treatment of chronic hepatitis B virus (HBV) infection, today ... appointed to its Scientific Advisory Board (SAB).  ... SAB," said Christian S. Schade , Chief Executive ... development experience which will be invaluable to Novira as ...
Breaking Biology Technology:PAWSitively Curing Cancer, Inc. Launched By Two Children for National Pet Cancer Awareness Month 2PAWSitively Curing Cancer, Inc. Launched By Two Children for National Pet Cancer Awareness Month 3PDL BioPharma Announces Successful Conclusion of Debt Financing Agreement with Durata Therapeutics 2Novira Therapeutics Announces Appointment of Brian F. Daniels, M.D., to its Scientific Advisory Board 2Novira Therapeutics Announces Appointment of Brian F. Daniels, M.D., to its Scientific Advisory Board 3
... AMLN ) will be presenting at the FBR ... 28, 2008 at 9:45 a.m. ET / 6:45,a.m. PT. ... Pharmaceuticals, will be providing a corporate overview., The ... a,recording will be made available following the event. The ...
... AstraZeneca (NYSE:,AZN) announced today that it supports ... the company,s latest step to provide the public,with ... Sponsored by Sens. Charles Grassley of Iowa ... a national registry of payments that,biopharmaceutical companies, device ...
... Biosciences,Corporation (Nasdaq: MATK ) announced that it intends ... 2008 on June 4, 2008, at approximately 4:00,p.m. Eastern ... Martek will,conduct a conference call to discuss the results ... interested parties may listen to the call,live via webcast ...
Cached Biology Technology:AstraZeneca Supports Transparency Legislation on Payments to Health Care Providers 2
(Date:11/15/2014)... , Nov. 13, 2014  While we may still be ... McCoy used in "Star Trek" to gain instant access to ... to work with smartphones and tablets for monitoring and measuring ... healthcare world. This may seem a tad Orwellian to some, ... adopt some of these technological opportunities into their healthcare regime. ...
(Date:11/7/2014)... conjunction with the Glendale and ... the Verdugos has announced the " GLENDALE - ... to keep the Verdugo Regional Crime Lab operational after its ... existence, the Lab has processed more than 400 DNA samples, ... "Because our number one priority is the wellbeing of ...
(Date:11/6/2014)... November 6, 2014 - Insilico Medicine, Inc, a ... and age related diseases announced a research collaboration ... cancer, Champions Oncology, Inc (OTC: CSBR). , "There ... personalized medicine, but Champions Oncology,s TumorGraft technology is ... the chemotherapy regimen experimentally generating vast amounts of ...
Breaking Biology News(10 mins):Americans May Be Ready for a Brave New World of Healthcare 2Americans May Be Ready for a Brave New World of Healthcare 3Americans May Be Ready for a Brave New World of Healthcare 4Community Foundation Of The Verdugos Unveils Campaign To Fund Glendale-Burbank DNA Justice Project 2Insilico Medicine, Inc announces research collaboration with Champions Oncology, Inc 2
... Scientists from the LSU Museum of Natural Science, or MNS, ... ornithological research programs in the world. This study the ... only shaken up the avian evolutionary tree, but completely redrawn ... heavily upon the LSU MNS, genetic resources collection, will be ...
... DCA groundbreaking new study finds that genes significantly affect ... reasons why people vote and participate in the political ... H. Fowler, Christopher T. Dawes (of UC San Diego) ... California), appears in the May issue of the ...
... together the latest science from research groups around Australia, ... agricultural sectors, with a focus on steps that can ... our climate. , Speaking to the Farm Writers Association ... CSIRO scientist Dr Mark Howden, said it was time ...
Cached Biology News:'Early bird' project really gets the worm 2Why do people vote? Genetic variation in political participation 2
Kit includes your choice of reagents for labeling 3 x 10 9 cells and EasySep magnet....
Plasmid expressing PLAP reporter gene....
Puromycin resistance gene (pac), provided in a pORF plasmid. pORF is an expression plasmid selectable with Ampicillin....
...
Biology Products: